Misoprostol for cervical ripening and labor induction.
Votipka
J R
JR
University of Virginia Health Sciences Center, Charlottesville, USA. dslawson@virginia.edu
D000282:Administration, Intravaginal; D002584:Cervix Uteri / Q000187:drug effects*; D002585:Cesarean Section; D036861:Delivery, Obstetric; D015232:Dinoprostone / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007751:Labor, Induced; D016595:Misoprostol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010120:Oxytocics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011247:Pregnancy
D010120:Oxytocics; D010919:Placebos; D016595:Misoprostol; D015232:Dinoprostone